Company news

Jasper Therapeutics, Inc. news in 2026

Jasper Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Jasper Therapeutics Announces 1-for-30 Reverse Stock Split

November 4, 2026

Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy

October 15, 2026

Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants

October 7, 2026

Jasper Therapeutics Announces Key Regulatory and Clinical Appointments

September 15, 2026

Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 9, 2026

Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

August 17, 2026

Jasper Therapeutics Announces Merger with Kira Pharmaceuticals

July 16, 2026

Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

May 31, 2026

Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

May 14, 2026

Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update

March 29, 2026

Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference

February 24, 2026

Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria

January 8, 2026

Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth

January 7, 2026

Decks in 2026